PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 INFECTIONS IN NIGERIA

被引:23
|
作者
OLALEYE, OD
BERNSTEIN, L
EKWEOZOR, CC
SHENG, ZJ
OMILABU, SA
LI, XY
SULLIVANHALLEY, J
RASHEED, S
机构
[1] UNIV SO CALIF,SCH MED,VIRAL ONCOL & AIDS RES LAB,1840 N SOTO ST,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT PREVENT MED,LOS ANGELES,CA 90033
[3] UNIV HOSP IBADAN,COLL MED,IBADAN,NIGERIA
来源
JOURNAL OF INFECTIOUS DISEASES | 1993年 / 167卷 / 03期
关键词
D O I
10.1093/infdis/167.3.710
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence of human immunodeficiency virus (HIV) types 1 and 2 infections in Nigeria was estimated from 3854 serum samples collected at 21 locations from 1985 to 1990. Seventy-eight samples (2.0%) were reactive for HIV-1 and 49 (1.3%) for HIV-2 antibodies; 5 samples were reactive for both viruses. The prevalence of HIV-1 and -2 infections, respectively, was highest among 60 female prostitutes, with 10% and 6.7% positive. For other groups the respective rates of positivity were 4.1% and 3.4% in 610 patients with sexually transmitted diseases, 3.6% and 1.4% in 140 tuberculosis patients, 1.6% and 0.6% of 1253 other medical patients, and 1.2% and 0.9% of 1640 volunteer blood donors. Of 153 health care workers, 1.3% were positive for HIV-1 only. The age group from 20 to 29 years had the highest prevalences of HIV-1 (3.3%) and -2 (2.2%). In Nigeria, antibody prevalence for both viruses appears to have increased > 10-fold between 1986 and 1990.
引用
收藏
页码:710 / 714
页数:5
相关论文
共 50 条
  • [1] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    EMERMAN, M
    GUYADER, M
    MONTAGNIER, L
    BALTIMORE, D
    MUESING, MA
    EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
  • [2] IMMUNOPRECIPITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 GLYCOPROTEINS BY SERA POSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ESPEJO, RT
    URIBE, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2107 - 2110
  • [3] INFECTION OF NONLYMPHOID CELLS BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 OR TYPE-2
    IKEUCHI, K
    KIM, S
    BYRN, RA
    GOLDRING, SR
    GROOPMAN, JE
    JOURNAL OF VIROLOGY, 1990, 64 (09) : 4226 - 4231
  • [4] ACQUIRED IMMUNODEFICIENCY WITHOUT EVIDENCE OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    LAURENCE, J
    SIEGAL, FP
    SCHATTNER, E
    GELMAN, IH
    MORSE, S
    LANCET, 1992, 340 (8814): : 273 - 274
  • [5] COMPARISON OF VERTICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMISSION IN THE FRENCH PROSPECTIVE COHORT
    COURPOTIN, C
    SIMON, F
    MATHERON, S
    FIRTION, G
    DECREPY, A
    CIRARUVIGNERON, N
    MAZI, F
    FLOCH, C
    MEIER, F
    TALON, P
    MEYOHAS, MC
    DANDINE, M
    HERVE, F
    DIMARIA, H
    MEHARZIE, X
    ALLEMON, C
    NOSEDA, G
    VIAL, M
    DELFRAISSY, JF
    CHAMBRIN, V
    RETALI, B
    MOUCHINO, F
    HELLER, C
    PASCAL, C
    VINAS, A
    LACHASSINE, E
    JEANTILS, V
    WIPFF, P
    BOTTO, C
    BLANCHE, S
    VEBER, F
    BURGARD, M
    TERRIS, J
    ROUZIOUX, C
    GRISCELLI, C
    BRUNNER, C
    SEGUY, X
    DOUARD, D
    FLEURY, H
    MICHEL, G
    TAMALET, C
    DOUSSIN, A
    MOUDOUB, Y
    LAURENT, C
    MAYAUX, MJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (06) : 502 - 506
  • [6] DETECTION AND QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 AND TYPE-2 ANTIGENS
    FEDYUK, NV
    KONOVALOV, EE
    LOKTEV, VB
    URYVAEV, IV
    KULYANDIN, SA
    POKROVSKY, AG
    VOPROSY VIRUSOLOGII, 1992, 37 (03) : 135 - 138
  • [7] INFECTION OF MACACA-NEMESTRINA BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    MORTON, WR
    SCHMIDT, AM
    AGY, MB
    KATZE, MG
    FLOREY, MJ
    COREY, L
    FRUMKIN, LR
    OCHS, HD
    HU, SL
    MCCLURE, J
    BENVENISTE, RE
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S86 - S86
  • [8] CROSS-NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 AND SIMIAN IMMUNODEFICIENCY VIRUS ISOLATES
    ROBERTGUROFF, M
    ALDRICH, K
    MULDOON, R
    STERN, TL
    BANSAL, GP
    MATTHEWS, TJ
    MARKHAM, PD
    GALLO, RC
    FRANCHINI, G
    JOURNAL OF VIROLOGY, 1992, 66 (06) : 3602 - 3608
  • [9] DOUBLE INFECTIONS WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 AND TYPE-2 IN SPANISH SUBJECTS
    GORRINO, MT
    MATEOS, MM
    SARRIA, L
    CISTERNA, R
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (12) : 1118 - 1119
  • [10] SPECIFIC-INHIBITION OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND THE CHIMERIC ENZYMES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 BY NONNUCLEOSIDE INHIBITORS
    HIZI, A
    TAL, R
    SHAHARABANY, M
    CURRENS, MJ
    BOYD, MR
    HUGHES, SH
    MCMAHON, JB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 1037 - 1042